Results 191 to 200 of about 54,240 (219)
Some of the next articles are maybe not open access.
Combination Antithrombotic Management for Non–ST Segment Elevation Acute Coronary Syndromes
Interventional Cardiology Clinics, 2013Patients with non-ST segment elevation acute coronary syndromes (NSTEACS) are at high risk for subsequent thrombotic events. Combination antithrombotic management with anticoagulant and antiplatelet medications can improve outcomes in these high-risk patients.
Jayant, Bagai +2 more
openaire +2 more sources
Antiplatelet Therapy in Non–ST-Segment Elevation Acute Coronary Syndromes
JAMA, 2004Acute coronary syndromes are a frequent cause of hospital admission for patients with coronary artery disease. The pathophysiology of acute coronary syndromes often involves plaque rupture or fissure with platelet aggregation. Recognition of the importance of platelet aggregation resulted in several large randomized trials testing 3 types of platelet ...
openaire +2 more sources
Cardiogenic Shock Complicating Non-ST-Segment Elevation Acute Coronary Syndrome
2002Classically, cardiogenic shock has been considered a sequela of ST-segment elevation myocardial infarction, most commonly caused by left ventricular dysfunction resulting from ongoing ischemia and cell necrosis. In keeping with this scenario, most of the current literature on cardiogenic shock confines itself to ST-segment elevation.
David R. Holmes, David Hasdai
openaire +1 more source
Non-ST-Segment Elevation Acute Coronary Syndromes (NSTE-ACS)
2018Despite advances in prevention, diagnosis, and treatment of coronary artery disease (CAD), non-ST segment elevation acute coronary syndromes (NSTE-ACS) remain a major cause of morbidity and mortality worldwide. There has been a significant decrease in mortality in the last several decades, which has been less prominent in women.
Justin Lee +2 more
openaire +1 more source
Unstable Angina and Non-ST Segment Elevation Acute Coronary Syndrome
DeckerMed Emergency Medicine, 2020Unstable angina and non-ST-segment acute coronary syndrome represent a frequent and serious presentation to the emergency department. While most patients present with chest discomfort, atypical presentations warrant that clinicians maintain a high index of suspicion. This review summarizes the present nomenclature, definitions, and pathophysiology for
openaire +1 more source
Pathogenesis and Early Management of Non–ST-segment Elevation Acute Coronary Syndromes
Cardiology Clinics, 2006NSTE ACS is a clinically significant problem. Endothelial dysfunction triggered by traditional cardiovascular risk factors (and perhaps by other as yet unidentified risks) in the susceptible host leads to the formation and development of atherosclerotic plaque.
Tomas H, Ayala, Steven P, Schulman
openaire +2 more sources
Assessing Performance and Quality After Non-ST Segment Elevation Acute Coronary Syndromes
Current Cardiology Reports, 2018This review summarizes and discusses the evidence base supporting current performance and quality measures used in assessing institutions in their care of patients with non-ST segment elevation acute coronary syndromes (NSTE-ACS).Professional societies in the USA and Europe have developed performance and quality measures for NSTE-ACS.
H Vernon, Anderson, Robin, Jacob
openaire +2 more sources
Management of non-ST-segment elevation acute coronary syndromes: Introduction
American Journal of Health-System Pharmacy, 2010While it was once believed that the primary physiological function of platelets was mediation of cellular hemostasis, it is now understood that activated platelets have a crucial role in the pathobiology of a variety of processes, including inflammation, leukocyte adhesion, progression ...
openaire +1 more source
Non-ST Segment Elevation Acute Coronary Syndromes
Southern Medical Journal, 2006Arun Kalyanasundaram +2 more
openaire +1 more source
Prasugrel Versus Ticagrelor in Non–ST-Segment Elevation Acute Coronary Syndrome
Journal of the American College of Cardiology, 2021Chia Siang, Kow +2 more
openaire +2 more sources